| Smokeless Tobacco Can Also Increase Cancer Risk |
| A review published in The Lancet Oncology finds that although users of smokeless tobacco products (STPs) likely have a lower cancer risk than smokers, they are still increasing their risk of developing several types of cancer. In the USA and Sweden, a finely cut or powered, flavored tobacco called moist snuff is the most popular form of STP used. In places like India, there is a wide range of products that are regularly consumed. |
| Emerging Clinical Data Continues To Support CyberKnife Radiosurgery For The Treatment Of Lung Cancer |
| Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced that emerging clinical data continues to support CyberKnife radiosurgery for the treatment of lung cancer, following a study published in the July 2008 issue of Clinical Lung Cancer. |
| Gene Panel Predicts Lung Cancer Survival |
| Researchers from four leading cancer centers have confirmed that an analysis involving a panel of genes can be used to predict which lung cancer patients will have the worst survival. The finding could one day lead to a test that would help determine who needs more aggressive treatment. The study, the largest of its kind, appears online in Nature Medicine. |
| FDA Reviewing Biomoda Submission For Cancer Screening Study |
| Biomoda, Inc. (OTC Bulletin Board: BMOD) (http://www.biomoda.com), a development stage medical diagnostics company, submitted to the FDA a pre-IDE (Investigational Device Exemption) protocol for a clinical study using Biomoda's proprietary assay for detection of early lung cancer in veterans. The New Mexico state legislature allocated more than $1. |
| Enzyme That Sensitizes Cells To Chemotherapeutics Could Also Be New Anti-cancer Target |
| Researchers at Van Andel Institute (VAI) and Novartis Institutes for Biomedical Research have identified an important enzyme required for cancer cell survival. Lowering levels of the enzyme caused a wide variety of cancer cells to die, reduced proliferation of cancer cells, and sensitized cancer cells to commonly used chemotherapeutic agents, such as the drug Taxol. The cells in the study included pancreatic, prostate, and lung cancer cells. |